We have been working with Rephine for many years on multiple projects, and their expertise, professionalism, and deep understanding of regulatory requirements never fail to impress us. Their guidance throughout the DMF submission was key for our success.
About this Case Study
An international API manufacturer partnered with Rephine to navigate China’s complex Drug Master File (DMF) submission process. Rephine’s cross-border team ensured compliance with NMPA guidelines, provided accurate translations, acted as the local regulatory agent, and managed CDE deficiency responses—streamlining approval.
The result was a fully compliant DMF and accelerated market access, supported by Rephine’s dual-region expertise.
“Rephine’s deep regulatory knowledge and responsiveness were crucial to our successful approval in China.”
— Panreac Quimica
Learn how Rephine can simplify your market entry and download the full case study now.
Download the Case Study
View other our other resources and company news
CAPA Strengthening CAPA & Exceptions Management
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
Article 100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance
Blog Data Governance & AI in Pharma | Ensuring Trust & Compliance
Case Study Global Audit Management for Pharma Company
Blog 